Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Pierfranco, Terrosu"'
Autor:
Giuseppe Damiano Sanna, Giuseppe Talanas, Giuseppina Fiore, Antonella Canu, Pierfranco Terrosu
Publikováno v:
Journal of the Saudi Heart Association, Vol 28, Iss 4, Pp 278-282 (2016)
Pheochromocytoma is a rare neuroendocrine tumor with a highly variable clinical presentation. The serious and potentially lethal cardiovascular complications of these tumors are related to the effects of secreted catecholamines. We describe a case of
Externí odkaz:
https://doaj.org/article/c4ebf49b6399464ba14b1b2f2ba2e478
Publikováno v:
Hellenic Journal of Cardiology, Vol 57, Iss 1, Pp 48-52 (2016)
Externí odkaz:
https://doaj.org/article/de05b67b02074e29a86bdd7127e0fcef
Autor:
Mario Bo, Alessandro Boccanelli, Pierfranco Terrosu, Giuseppe Palazzo, Niccolò Marchionni, Antonio Coscarelli, Giovanni Zito, Francesco Vetta, Giulia Rivasi, Samuele Baldasseroni, Andrea Ungar, Paolo Alboni, Giovambattista Desideri, Renzo Rozzini
Publikováno v:
Minerva Medica. 113
Over recent years, managing hypertension in older people has gained increasing attention, with reference to very old, frailer individuals. In these patients, hypertension treatment may be challenging due to a higher risk of hypotension-related advers
Autor:
Enrico Brunetti, Giovanni Zito, Giovambattista Desideri, Niccolò Marchionni, Stefano Fumagalli, Mario Bo, Paolo Alboni, Pierfranco Terrosu, Francesco Vetta, Samuele Baldasseroni, Renzo Rozzini, Andrea Ungar, Gianluca Isaia, Alessandro Boccanelli
Publikováno v:
Minerva Medica. 113
Introduction Atrial fibrillation (AF) is the most common cardiac sustained arrhythmia, whose incidence and prevalence increase with age, representing a significant burden for health services in western countries. Older people contribute to the vast m
Autor:
Samuele, Baldasseroni, Francesco, Orso, Andrea, Herbst, Mario, Bo, Alessandro, Boccanelli, Giovanbattista, Desideri, Renzo, Rozzini, Pierfranco, Terrosu, Paolo, Alboni, Niccolò, Marchionni, Andrea, Ungar
Publikováno v:
Minerva Medica. 113
During earliest years, new drug-therapies and novel interventional therapies have been tested to modify the detrimental effect of secondary valve diseases, adverse ventricular remodelling and persistent fluid overload in HF patients. However, the inc
Autor:
Pierfranco Terrosu
Publikováno v:
Monaldi Archives for Chest Disease, Vol 84, Iss 1-2 (2016)
The net clinical benefit of aspirin in primary prevention is uncertain as the reduction in occlusive events needs to be balanced against the increase in gastro-intestinal and cerebral bleedings. The meta-analysis of ATT (Anti Thrombotic Trialists) Co
Externí odkaz:
https://doaj.org/article/47493bda865e44658d266b8f2f9141c4
Autor:
Pierfranco Terrosu
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
Albeit largely underappreciated, chronic obstructive pulmonary disease (COPD) constitutes a major risk factor for cardiovascular diseases in general and for coronary disease in particular. The incidence of myocardial infarction, in fact increases rap
Autor:
Renzo ROZZINI, Angelo BIANCHETTI, Paolo ALBONI, Samuele BALDASSERONI, Mario BO, Alessandro BOCCANELLI, Giovambattista DESIDERI, Niccolò MARCHIONNI, Giuseppe PALAZZO, Pierfranco TERROSU, Andrea UNGAR, Francesco VETTA, Giovanni ZITO
Principles and processes of comprehensive geriatric assessment (CGA) are increasingly being applied to subspecialties and subspecialty conditions, including cardiovascular patients (i.e., infective endocarditis; considerations of surgery or transcath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4bb460353c44d90d318fbdd663ac46
http://hdl.handle.net/2318/1851570
http://hdl.handle.net/2318/1851570
Autor:
Angelo B. Cefalù, Raffaella Garbelotto, Giuliana Mombelli, Matteo Pirro, Paolo Rubba, Marcello Arca, Claudio Borghi, Katia Bonomo, Stefano Gonnelli, Katia Massaroni, Giampaolo Tirone, Maurizio Averna, Francesco Angelico, Francesco Cipollone, Enzo Corghi, Pompilio Faggiano, Cesare Greco, Luigina Guasti, Tiziano Lucchi, Carlo Sabba, Riccardo Sarzani, Pierfranco Terrosu, Alberto Zambon
Publikováno v:
Nutrition, metabolism, and cardiovascular diseases : NMCD. 32(11)
ODYSSEY APPRISE trial evaluated efficacy and safety of alirocumab in 994 patients with hypercholesterolemia and high CV risk in a real-life setting. The aim of the present report is to detail on the Italian cohort enrolled and treated in the trial.Th
Autor:
Mario Bo, Samuele Baldasseroni, Andrea Ungar, Niccolò Marchionni, Pierfranco Terrosu, Giuseppe Palazzo, Renzo Rozzini, Giovambattista Desideri, Giuseppe Sabino, Alessandro Boccanelli, Giovanni Zito, Francesco Vetta, Paolo Alboni
Introduction Recently, transcatheter aortic valve replacement (TAVR) has emerged as established standard treatment for symptomatic severe aortic stenosis, providing an effective, less-invasive alternative to open cardiac surgery for inoperable or hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a067baf58fadb72f862e0d42f3930f31
http://hdl.handle.net/2318/1817691
http://hdl.handle.net/2318/1817691